{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:35:57Z","timestamp":1780572957285,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1038\/leu.2014.120","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T10:30:17Z","timestamp":1396607417000},"page":"2165-2177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia"],"prefix":"10.1038","volume":"28","author":[{"given":"A","family":"Chorzalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Shafqat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Marjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Treaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Schorl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C R","family":"Bryke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T C","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Reagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Al-Homsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kouttab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Dubielecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"BFleu2014120_CR1","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/leu.2010.159","volume":"24","author":"I Sloma","year":"2010","unstructured":"Sloma I, Jiang X, Eaves AC, Eaves CJ . Insights into the stem cells of chronic myeloid leukemia. Leukemia 2010; 24: 1823\u20131833.","journal-title":"Leukemia"},{"key":"BFleu2014120_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ . Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 2011; 121: 396\u2013409.","journal-title":"J Clin Invest"},{"key":"BFleu2014120_CR3","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","volume":"118","author":"JC Chomel","year":"2011","unstructured":"Chomel JC, Bonnet ML, Sorel N, Bertrand A, Meunier MC, Fichelson S et al. Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood 2011; 118: 3657\u20133660.","journal-title":"Blood"},{"key":"BFleu2014120_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876\u2013880.","journal-title":"Science"},{"key":"BFleu2014120_CR5","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1158\/0008-5472.CAN-05-0076","volume":"65","author":"DJ Barnes","year":"2005","unstructured":"Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A et al. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia. Cancer Res 2005; 65: 8912\u20138919.","journal-title":"Cancer Res"},{"key":"BFleu2014120_CR6","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/sj.leu.2402309","volume":"15","author":"K Keeshan","year":"2001","unstructured":"Keeshan K, Mills KI, Cotter TG, McKenna SL . Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia 2001; 15: 1823\u20131833.","journal-title":"Leukemia"},{"key":"BFleu2014120_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu Y, Chen Y, Douglas L, Li S . beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 2009; 23: 109\u2013116.","journal-title":"Leukemia"},{"key":"BFleu2014120_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/sj.leu.2404609","volume":"21","author":"X Jiang","year":"2007","unstructured":"Jiang X, Zhao Y, Smith C, Gasparetto M, Turhan A, Eaves A et al. Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia 2007; 21: 926\u2013935.","journal-title":"Leukemia"},{"key":"BFleu2014120_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.leu.2405086","volume":"22","author":"H Konig","year":"2008","unstructured":"Konig H, Holtz M, Modi H, Manley P, Holyoake TL, Forman SJ et al. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia 2008; 22: 748\u2013755.","journal-title":"Leukemia"},{"key":"BFleu2014120_CR10","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1172\/JCI60238","volume":"122","author":"J Hoggatt","year":"2012","unstructured":"Hoggatt J, Scadden DT . The stem cell niche: tissue physiology at a single cell level. J Clin Invest 2012; 122: 3029\u20133034.","journal-title":"J Clin Invest"},{"key":"BFleu2014120_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2741\/3913","volume":"17","author":"D Park","year":"2012","unstructured":"Park D, Sykes DB, Scadden DT . The hematopoietic stem cell niche. Front Biosci 2012; 17: 30\u201339.","journal-title":"Front Biosci"},{"key":"BFleu2014120_CR12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","volume":"114","author":"SW Lane","year":"2009","unstructured":"Lane SW, Scadden DT, Gilliland DG . The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 2009; 114: 1150\u20131157.","journal-title":"Blood"},{"key":"BFleu2014120_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm909","volume":"9","author":"T Matsunaga","year":"2003","unstructured":"Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003; 9: 1158\u20131165.","journal-title":"Nat Med"},{"key":"BFleu2014120_CR14","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1182\/blood.V96.5.1926","volume":"96","author":"RE Mudry","year":"2000","unstructured":"Mudry RE, Fortney JE, York T, Hall BM, Gibson LF . Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000; 96: 1926\u20131932.","journal-title":"Blood"},{"key":"BFleu2014120_CR15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3324\/haematol.2011.047993","volume":"96","author":"S Shalapour","year":"2011","unstructured":"Shalapour S, Hof J, Kirschner-Schwabe R, Bastian L, Eckert C, Prada J et al. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse. Haematologica 2011; 96: 1627\u20131635.","journal-title":"Haematologica"},{"key":"BFleu2014120_CR16","doi-asserted-by":"publisher","first-page":"953982","DOI":"10.1155\/2013\/953982","volume":"2013","author":"F Nwajei","year":"2013","unstructured":"Nwajei F, Konopleva M . The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells. Adv Hematol 2013; 2013: 953982.","journal-title":"Adv Hematol"},{"key":"BFleu2014120_CR17","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1101\/gad.9.21.2583","volume":"9","author":"Y Shi","year":"1995","unstructured":"Shi Y, Alin K, Goff SP . Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev 1995; 9: 2583\u20132597.","journal-title":"Genes Dev"},{"key":"BFleu2014120_CR18","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.0900653106","volume":"106","author":"M Brehme","year":"2009","unstructured":"Brehme M, Hantschel O, Colinge J, Kaupe I, Planyavsky M, Kocher T et al. Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci USA 2009; 106: 7414\u20137419.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014120_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/45822","volume":"401","author":"G Scita","year":"1999","unstructured":"Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S et al. EPS8 and E3B1 transduce signals from Ras to Rac. Nature 1999; 401: 290\u2013293.","journal-title":"Nature"},{"key":"BFleu2014120_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1083\/jcb.200103146","volume":"154","author":"G Scita","year":"2001","unstructured":"Scita G, Tenca P, Areces LB, Tocchetti A, Frittoli E, Giardina G et al. An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J Cell Biol 2001; 154: 1031\u20131044.","journal-title":"J Cell Biol"},{"key":"BFleu2014120_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/ncb1745","volume":"10","author":"P Beli","year":"2008","unstructured":"Beli P, Mascheroni D, Xu D, Innocenti M . WAVE and Arp2\/3 jointly inhibit filopodium formation by entering into a complex with mDia2. Nat Cell Biol 2008; 10: 849\u2013857.","journal-title":"Nat Cell Biol"},{"key":"BFleu2014120_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ncb1304","volume":"7","author":"M Innocenti","year":"2005","unstructured":"Innocenti M, Gerboth S, Rottner K, Lai FP, Hertzog M, Stradal TE et al. Abi1 regulates the activity of N-WASP and WAVE in distinct actin-based processes. Nat Cell Biol 2005; 7: 969\u2013976.","journal-title":"Nat Cell Biol"},{"key":"BFleu2014120_CR23","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1128\/MCB.01483-08","volume":"29","author":"JR Ryu","year":"2009","unstructured":"Ryu JR, Echarri A, Li R, Pendergast AM . Regulation of cell-cell adhesion by Abi\/Diaphanous complexes. Mol Cell Biol 2009; 29: 1735\u20131748.","journal-title":"Mol Cell Biol"},{"key":"BFleu2014120_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ncb1105","volume":"6","author":"M Innocenti","year":"2004","unstructured":"Innocenti M, Zucconi A, Disanza A, Frittoli E, Areces LB, Steffen A et al. Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nat Cell Biol 2004; 6: 319\u2013327.","journal-title":"Nat Cell Biol"},{"key":"BFleu2014120_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1083\/jcb.200206079","volume":"160","author":"M Innocenti","year":"2003","unstructured":"Innocenti M, Frittoli E, Ponzanelli I, Falck JR, Brachmann SM, Di Fiore PP et al. Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J Cell Biol 2003; 160: 17\u201323.","journal-title":"J Cell Biol"},{"key":"BFleu2014120_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/ncb1096","volume":"6","author":"P Sini","year":"2004","unstructured":"Sini P, Cannas A, Koleske AJ, Di Fiore PP, Scita G . Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nat Cell Biol 2004; 6: 268\u2013274.","journal-title":"Nat Cell Biol"},{"key":"BFleu2014120_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/sj.cr.7310091","volume":"16","author":"F Campa","year":"2006","unstructured":"Campa F, Machuy N, Klein A, Rudel T . A new interaction between Abi-1 and betaPIX involved in PDGF-activated actin cytoskeleton reorganisation. Cell Res 2006; 16: 759\u2013770.","journal-title":"Cell Res"},{"key":"BFleu2014120_CR28","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1016\/j.febslet.2010.06.029","volume":"584","author":"PM Dubielecka","year":"2010","unstructured":"Dubielecka PM, Machida K, Xiong X, Hossain S, Ogiue-Ikeda M, Carrera AC et al. Abi1\/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells. FEBS Lett 2010; 584: 3279\u20133286.","journal-title":"FEBS Lett"},{"key":"BFleu2014120_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1073\/pnas.1012316108","volume":"108","author":"C Ring","year":"2011","unstructured":"Ring C, Ginsberg MH, Haling J, Pendergast AM . Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the alpha4 integrin. Proc Natl Acad Sci USA 2011; 108: 149\u2013154.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014120_CR30","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.1073\/pnas.1016811108","volume":"108","author":"PM Dubielecka","year":"2011","unstructured":"Dubielecka PM, Ladwein KI, Xiong X, Migeotte I, Chorzalska A, Anderson KV et al. Essential role for Abi1 in embryonic survival and WAVE2 complex integrity. Proc Natl Acad Sci USA 2011; 108: 7022\u20137027.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014120_CR31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1242\/dev.121.2.549","volume":"121","author":"JT Yang","year":"1995","unstructured":"Yang JT, Rayburn H, Hynes RO . Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 1995; 121: 549\u2013560.","journal-title":"Development"},{"key":"BFleu2014120_CR32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1242\/dev.121.2.489","volume":"121","author":"L Kwee","year":"1995","unstructured":"Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA et al. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 1995; 121: 489\u2013503.","journal-title":"Development"},{"key":"BFleu2014120_CR33","first-page":"7149","volume":"62","author":"P La Rosee","year":"2002","unstructured":"La Rosee P, Corbin AS, Stoffregen EP, Deininger MW, Druker BJ . Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571). Cancer Res 2002; 62: 7149\u20137153.","journal-title":"Cancer Res"},{"key":"BFleu2014120_CR34","first-page":"188","volume":"62","author":"C Yu","year":"2002","unstructured":"Yu C, Krystal G, Varticovksi L, McKinstry R, Rahmani M, Dent P et al. Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells. Cancer Res 2002; 62: 188\u2013199.","journal-title":"Cancer Res"},{"key":"BFleu2014120_CR35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766","volume":"95","author":"P le Coutre","year":"2000","unstructured":"le Coutre P, Tassi E, Varella-Garcia M, Barni R, Mologni L, Cabrita G et al. Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood 2000; 95: 1758\u20131766.","journal-title":"Blood"},{"key":"BFleu2014120_CR36","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1182\/blood-2012-01-406272","volume":"121","author":"YT Hsieh","year":"2013","unstructured":"Hsieh YT, Gang EJ, Geng H, Park E, Huantes S, Chudziak D et al. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood 2013; 121: 1814\u20131818.","journal-title":"Blood"},{"key":"BFleu2014120_CR37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1101\/gad.12.10.1415","volume":"12","author":"Z Dai","year":"1998","unstructured":"Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW et al. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev 1998; 12: 1415\u20131424.","journal-title":"Genes Dev"},{"key":"BFleu2014120_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1200\/JCO.2010.31.0904","volume":"29","author":"MY Konopleva","year":"2011","unstructured":"Konopleva MY, Jordan CT . Leukemia stem cells and microenvironment: biology and therapeutic targeting. J Clin Oncol 2011; 29: 591\u2013599.","journal-title":"J Clin Oncol"},{"key":"BFleu2014120_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/jmcb\/mjs010","volume":"4","author":"A Puissant","year":"2012","unstructured":"Puissant A, Dufies M, Fenouille N, Ben Sahra I, Jacquel A, Robert G et al. Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. J Mol Cell Biol 2012; 4: 207\u2013220.","journal-title":"J Mol Cell Biol"},{"key":"BFleu2014120_CR40","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/eji.1830220434","volume":"22","author":"M Rubio","year":"1992","unstructured":"Rubio M, Nueda A, Vara A, Corbi Lopez AL . A single mRNA encodes the alpha 150 and alpha 80\/70 forms of the alpha subunit of VLA4. Eur J Immunol 1992; 22: 1099\u20131102.","journal-title":"Eur J Immunol"},{"key":"BFleu2014120_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/10428199709055581","volume":"24","author":"RA Oostendorp","year":"1997","unstructured":"Oostendorp RA, Dormer P . VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk Lymphoma 1997; 24: 423\u2013435.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2014120_CR42","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1182\/blood-2006-10-051276","volume":"110","author":"H Qian","year":"2007","unstructured":"Qian H, Georges-Labouesse E, Nystrom A, Domogatskaya A, Tryggvason K, Jacobsen SE et al. Distinct roles of integrins alpha6 and alpha4 in homing of fetal liver hematopoietic stem and progenitor cells. Blood 2007; 110: 2399\u20132407.","journal-title":"Blood"},{"key":"BFleu2014120_CR43","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI23445","volume":"115","author":"B Garmy-Susini","year":"2005","unstructured":"Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner J . Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 2005; 115: 1542\u20131551.","journal-title":"J Clin Invest"},{"key":"BFleu2014120_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/leu.2012.254","volume":"27","author":"H Bonig","year":"2013","unstructured":"Bonig H, Papayannopoulou T . Hematopoietic stem cell mobilization: updated conceptual renditions. Leukemia 2013; 27: 24\u201331.","journal-title":"Leukemia"},{"key":"BFleu2014120_CR45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/0008-5472.CAN-06-3166","volume":"67","author":"Y Tabe","year":"2007","unstructured":"Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007; 67: 684\u2013694.","journal-title":"Cancer Res"},{"key":"BFleu2014120_CR46","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","volume":"121","author":"B Zhang","year":"2013","unstructured":"Zhang B, Li M, McDonald T, Holyoake TL, Moon RT, Campana D et al. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling. Blood 2013; 121: 1824\u20131838.","journal-title":"Blood"},{"issue":"Pt 21","key":"BFleu2014120_CR47","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1242\/jcs.074112","volume":"124","author":"C Lo Celso","year":"2011","unstructured":"Lo Celso C, Scadden DT . The haematopoietic stem cell niche at a glance. J Cell Sci 2011; 124 (Pt 21): 3529\u20133535.","journal-title":"J Cell Sci"},{"key":"BFleu2014120_CR48","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.1158\/1078-0432.CCR-11-0396","volume":"17","author":"AM Stein","year":"2011","unstructured":"Stein AM, Bottino D, Modur V, Branford S, Kaeda J, Goldman JM et al. BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment. Clin Cancer Res 2011; 17: 6812\u20136821.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014120_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nchembio.954","volume":"8","author":"W Jankowski","year":"2012","unstructured":"Jankowski W, Saleh T, Pai MT, Sriram G, Birge RB, Kalodimos CG . Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII. Nat Chem Biol 2012; 8: 590\u2013596.","journal-title":"Nat Chem Biol"},{"key":"BFleu2014120_CR50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc2967","volume":"10","author":"S Cabodi","year":"2010","unstructured":"Cabodi S, del Pilar Camacho-Leal M, Di Stefano P, Defilippi P . Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 2010; 10: 858\u2013870.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2014120_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15\u201320.","journal-title":"Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:40:07Z","timestamp":1648744807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["BFleu2014120"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.120","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]},"assertion":[{"value":"25 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}